Sarahrudi, Kambiz <br/><br/>
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Apr 2004 
 - 1126-32 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1016/j.jtcvs.2003.11.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Australia--epidemiology<br/>Azathioprine--therapeutic use<br/>Bronchiolitis Obliterans--drug therapy<br/>Canada--epidemiology<br/>Chronic Disease<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Europe--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Forced Expiratory Volume--drug effects<br/>Graft Rejection--drug therapy<br/>Humans<br/>Hypertension, Pulmonary--surgery<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Kidney--drug effects<br/>Lung Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Postoperative Complications--drug therapy<br/>Pulmonary Disease, Chronic Obstructive--surgery<br/>Pulmonary Fibrosis--surgery<br/>Retrospective Studies<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Treatment Outcome